CSL Management
Management criteria checks 3/4
CSL's CEO is Paul McKenzie, appointed in Mar 2023, has a tenure of 2.58 years. total yearly compensation is $8.97M, comprised of 20.2% salary and 79.8% bonuses, including company stock and options. directly owns 0.006% of the company’s shares, worth A$5.63M. The average tenure of the management team and the board of directors is 2.6 years and 4.2 years respectively.
Key information
Paul McKenzie
Chief executive officer
US$9.0m
Total compensation
| CEO salary percentage | 20.16% |
| CEO tenure | 2.6yrs |
| CEO ownership | 0.006% |
| Management average tenure | 2.6yrs |
| Board average tenure | 4.2yrs |
Recent management updates
Recent updates
CSL Limited's (ASX:CSL) Share Price Not Quite Adding Up
Sep 25
Is CSL Limited (ASX:CSL) Trading At A 43% Discount?
Aug 07Here's Why CSL (ASX:CSL) Can Manage Its Debt Responsibly
Jun 14Weekly Picks: 🧠 Alphabet’s AI edge, CSL’s pricing power, and a chip underdog
Apr 16
CSL is undervalued in High Tax Scenario
CSL Behring: This is CSL's largest segment and the global leader (#1) in plasma therapies within an estimated US$30 billion industry.11 It focuses on researching, developing, manufacturing, and distri
Advancements In iNOMi Technology And HEMGENIX Will Strengthen Market Position
Advancements in plasma collection and operational efficiencies are set to reduce costs and improve CSL Behring's margins, potentially boosting overall earnings.Should You Be Adding CSL (ASX:CSL) To Your Watchlist Today?
Jan 31CSL Limited's (ASX:CSL) Intrinsic Value Is Potentially 43% Above Its Share Price
Jan 10With EPS Growth And More, CSL (ASX:CSL) Makes An Interesting Case
Nov 01CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2025 | US$9m | US$2m | US$3b |
| Mar 31 2025 | n/a | n/a | US$3b |
| Dec 31 2024 | n/a | n/a | US$3b |
| Sep 30 2024 | n/a | n/a | US$3b |
| Jun 30 2024 | US$8m | US$2m | US$3b |
| Mar 31 2024 | n/a | n/a | US$3b |
| Dec 31 2023 | n/a | n/a | US$2b |
| Sep 30 2023 | n/a | n/a | US$2b |
| Jun 30 2023 | US$4m | US$1m | US$2b |
| Mar 31 2023 | n/a | n/a | US$2b |
| Dec 31 2022 | n/a | n/a | US$2b |
| Sep 30 2022 | n/a | n/a | US$2b |
| Jun 30 2022 | US$5m | US$965k | US$2b |
| Mar 31 2022 | n/a | n/a | US$2b |
| Dec 31 2021 | n/a | n/a | US$2b |
| Sep 30 2021 | n/a | n/a | US$2b |
| Jun 30 2021 | US$6m | US$989k | US$2b |
| Mar 31 2021 | n/a | n/a | US$3b |
| Dec 31 2020 | n/a | n/a | US$3b |
| Sep 30 2020 | n/a | n/a | US$2b |
| Jun 30 2020 | US$7m | US$1m | US$2b |
Compensation vs Market: Paul's total compensation ($USD8.97M) is above average for companies of similar size in the Australian market ($USD3.87M).
Compensation vs Earnings: Paul's compensation has been consistent with company performance over the past year.
CEO
Paul McKenzie (59 yo)
Dr. Paul F. McKenzie, Ph.D. (Chemical Engineering), has been Chief Operating Officer at CSL Behring LLC since 2019. Dr. McKenzie serves as Chief Operating Officer at CSL Plasma Inc. Dr. McKenzie had been C...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| MD, CEO & Executive Director | 2.6yrs | US$8.97m | 0.0057% A$ 5.6m | |
| Chief Financial Officer | less than a year | US$3.70m | 0.0031% A$ 3.1m | |
| Executive Vice President of CSL Behring | 2.3yrs | US$3.59m | 0.0010% A$ 1.0m | |
| Chief Operating Officer | less than a year | no data | no data | |
| Head of Investor Relations | no data | no data | no data | |
| Executive VP of Legal & General Counsel | 16.8yrs | US$2.31m | no data | |
| Chief Human Resources Officer | 1.8yrs | no data | no data | |
| Chief Medical Officer | 7yrs | US$2.14m | no data | |
| Chief Digital Information Officer & Executive VP | 5yrs | no data | no data | |
| Senior Vice President of Research & Development Strategic Operations | no data | no data | no data | |
| Senior VP & GM of Vifor | 2.6yrs | no data | no data | |
| Executive VP & Chief Strategy Officer | no data | no data | no data |
Experienced Management: CSL's management team is considered experienced (2.6 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| MD, CEO & Executive Director | 2.8yrs | US$8.97m | 0.0057% A$ 5.6m | |
| Independent Non Executive Director | 9.7yrs | US$246.55k | 0.0012% A$ 1.2m | |
| Independent Non-Executive Director | 4.2yrs | US$253.45k | 0.00083% A$ 825.4k | |
| Independent Non-Executive Director | 5.8yrs | US$238.62k | 0.00054% A$ 537.0k | |
| Independent Non-Executive Chairman | 7.7yrs | US$612.35k | 0.026% A$ 26.2m | |
| Independent Non-Executive Director | 7yrs | US$223.98k | 0.015% A$ 14.6m | |
| Independent Non-executive Director | less than a year | US$135.56k | no data | |
| Independent Non-Executive Director | 12.2yrs | US$219.14k | 0.00092% A$ 914.9k | |
| Independent Non-executive Director | 1.8yrs | US$199.34k | 0.00046% A$ 457.4k | |
| Independent Non-Executive Director | 1.1yrs | US$194.62k | no data | |
| Director | no data | no data | 0.00068% A$ 676.2k |
Experienced Board: CSL's board of directors are considered experienced (4.2 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/10/07 13:51 |
| End of Day Share Price | 2025/10/07 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2025/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
CSL Limited is covered by 28 analysts. 16 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Saul Hadassin | Barrenjoey Markets Pty Limited |
| Thomas Wakim | Bell Potter |
| Lyanne Harrison | BofA Global Research |